Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma

International Journal of Gynecology and Obstetrics

Volumn 85, Issue 2, 2004, Pages 151-158

  Xie, X ^a   Ye, D ^a   Chen, H ^a   Lu, W ^a   Cheng, B ^a   Zhong, H ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Epithelial ovarian carcinoma; Immunity; Interleukin 7

Indexed keywords

INTERLEUKIN 7;

ADULT; ARTICLE; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PERITONEAL FLUID; PERITONEAL FLUID LEVEL; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 1942455795     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2003.08.015     Document Type: Article

References (19)

1. Asschert J.G., Vellenga E., Hollema H., Van-der-Zee A.G., de Vries E.G. Expression of macrophage colony-stimulating factor (M-CSF), interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta), interleukin-11(IL-11) and tumor necrosis factor-alpha(TNF-alpha) in p53-characterised human ovarian carcinomas. Eur J Cancer. 33:1997;2246-2251.
2. Zilterner H.J., Maines B.S., Schrader J.W., Auersperg N. Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium. Biol Reprod. 49:1993;635-641.
3. Kryczek I., Grybos M., Karabon L., Klimczak A., Lange A. IL-6 production in ovarian carcinoma is associated with histotype and biological characteristics of the tumor and influence local immunity. Br J Cancer. 82:2000;621-628.
4. Rathwell J.C., Farkash E.A., Gao W., Thompson C.B. IL-7 enhances the survival and maintains the size of naïve T cells. J Immunol. 167:2001;6869-6876.
5. Qin J.Z., Zhang C.L., Kamarashev J., Dummer R., Burg G., Dobbeling U. Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myc genes in cutaneous T-cell lymphoma cells. Blood. 98:2001;2778-2783.
6. Webb L.M., Foxwell B.M., Feldmann M. Putative role for interleukin-7 in the maintenance of the recirculating naïve CD4+ T cell pool. Immunology. 98:1999;400-405.
7. Bebo B.F. Jr, Schuster S.C., Adlard K., Vandenbark A.A., Offner H. Interleukin-7 is a potent co-stimulator of mylin specific T cells that enhances the adoptive transfer of experimental autoimmune encephalomyelitis. Cytokine. 12:2000;324-331.
8. Vakkila J., Aysto S., Saarinen-Pihkala U.M., Sariola H. Naïve CD4+ T cells can be sensitized with IL-7. Scand J Immunol. 54:2001;501-505.
9. Vicari A., de Moraes C., Gombert J.M., Dy M., Penit C., Papiernik M., et al. Interleukin 7 induces preferential expansion of V beta 8.2+CD4-8- and V beta 8.2+CD4+8- murine lymphocytes positively selected by class I molecules. J Exp Med. 180:1994;653-661.
10. Appasamy P.M., Kenniston T.W. Jr, Weng Y., Hdt H.C., Kost J., Chambers W.H. Interleukin-7 induced expression of specific T cell receptor gamma variable regions in murine fetal liver cultures. J Exp Med. 178:1993;2201-2206.
11. Sieling P.A., Sakimura L., Uyemura K., Yamamura M., Oliveros J., Nickoloff B.J., et al. IL-7 in the cell mediated immune response to a human pathogen. J Immunol. 154:1995;2775-2783.
12. Wanger L.A., Brown T., Cil S., Frank I., Carter W., Tamura R., et al. The keratinocyte-derived cytokine IL-7 increases adhesion of the epidermal T cell subset to the skin basement membrane protein laminin-5. Eur J Immunol. 29:1999;2530-2538.
13. Goodwin R.G., Lupton S., Schmierer A., Hjerrild K.J., Jerzy R., Clevenger W., et al. Human interleukin 7 molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA. 86:1989;302-306.
14. Maeurer M.J., Walter W., Martin D., Zitvogel L., Elder E., Storkus W., et al. Interleukin-7 (IL-7) in colorectal cancer: IL-7 is produced by tissues from colorectal cancer and promotes preferential expansion of tumor infiltrating lymphocytes. Scand J Immunol. 45:1997;182-192.
15. Trinder P., Seizer U., Gerdes J., Seliger B., Maeurer M. Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in human renal cell cancer. Int J Oncol. 14:1999;23-31.
16. Oka M., Hirose K., Lizuka N., Aoyagi K., Yamamoto K., Abe T., et al. Cytokine mRNA expression patterns in human esophageal cancer cell lines. J Interferon Cytokine Res. 15:1995;1005-1009.
17. Bristow R.E., Baldwin R.L., Yamada S.D., Korc M., Karlan B.Y. Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma. Cancer. 85:1999;658-668.
18. Merogi A.J., Marrogi A.J., Ramesh R., Robinson W.R., Fermin C.D., Freeman S.M. Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinoma. Human Pathology. 28:1997;321-331.
19. Radke J., Schmidt D., Bohme M., Schmidt U., Weise W., Morenz J. Cytokine level in malignant ascites and peripheral blood of patients with advanced ovarian carcinoma. Geburtshife Frauenheilkd. 56:1996;83-87.